Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep 7;14(9):1978.
doi: 10.3390/v14091978.

The Elegance of the Acyclic Nucleoside Phosphonates (ANPs), Honorary Tribute to Antonín Holý, Who Passed Away on 16 July 2012, at the 10th Anniversary of His Death

Erik De Clercq  1
Affiliations
Editorial

The Elegance of the Acyclic Nucleoside Phosphonates (ANPs), Honorary Tribute to Antonín Holý, Who Passed Away on 16 July 2012, at the 10th Anniversary of His Death

Erik De Clercq. Viruses. .

Abstract

My collaboration with Prof. Antonín Holý, that spans a period of 3-4 decades (1976-2012), led to the discovery of several acyclic nucleoside phosphonates (ANPs) which were clinically developed by Gilead Sciences: cidofovir, adefovir, and tenofovir. The latter was further converted to two orally bioavailable prodrug forms, TDF and TAF, and both TDF and TAF were further combined with other antiviral drugs, thus giving rise to a broad array of antiviral drug combinations for the treatment of HIV infections. TDF and TAF are both available for the treatment of hepatitis B virus (HBV) infections, and, in combination with emtricitabine, also applicable as Truvada® and Descovy®, respectively, for the prophylaxis of HIV infections.

Keywords: ANPs; HBV; HIV; PrEP; TAF; TDF; adefovir; cidofovir; tenofovir.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
DHPA.
Figure 2
Figure 2
HPMPA.
Figure 3
Figure 3
HPMPC (cidofovir, Vistide®).
Figure 4
Figure 4
PMEA (adefovir) → Adefovir dipivoxil (Hepsera®).
Figure 5
Figure 5
(R)-PMPA (Tenofovir) → Tenofovir disoproxil → Tenofovir disoproxil fumarate (TDF, Viread®).
Figure 6
Figure 6
Tenofovir alafenamide (TAF, Vemlidy®).
See this image and copyright information in PMC

References

    1. De Clercq E., Descamps J., De Somer P., Holý A. (S)-9-(2,3-dihydroxypropyl)adenine: An aliphatic nucleoside analog with broad-spectrum antiviral activity. Science. 1978;200:563–565. doi: 10.1126/science.200.4341.563. - DOI - PubMed
    1. Schaeffer H.J., Beauchamp L., de Miranda P., Elion G.B., Bauer D.J., Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978;272:583–585. doi: 10.1038/272583a0. - DOI - PubMed
    1. Elion G.B., Furman P.A., Fyfe J.A., de Miranda P., Beauchamp L., Schaeffer H.J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl. Acad. Sci. USA. 1977;74:5716–5720. doi: 10.1073/pnas.74.12.5716. - DOI - PMC - PubMed
    1. De Clercq E. S-Adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents. Biochem. Pharmacol. 1987;36:2567–2575. doi: 10.1016/0006-2952(87)90533-8. - DOI - PubMed
    1. De Clercq E. John Montgomery’s Legacy: Carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity. Nucleosides Nucleotides Nucleic Acids. 2005;24:1395–1415. doi: 10.1080/15257770500265638. - DOI - PubMed

Publication types

MeSH terms